The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Folate and Folate−PEG−PAMAM Dendrimers: Synthesis, Characterization, and Targeted Anticancer Drug Delivery Potential in Tumor Bearing Mice
Abstract
Ligand-mediated targeting of drugs especially in anticancer drug delivery is an effective approach. Dendrimers, due to unique surface topologies, can be a choice in this context. In the present study, PAMAM (polyamidoamine) dendrimers up to fourth generation were synthesized and characterized through infrared (IR), nuclear magnetic resonance (NMR), electrospray ionization (ESI) mass spectrometric, and transmission electron microscopic (TEM) techniques. Primary amines present on the dendritic surface were conjugated through folic acid and folic acid-PEG (poly(ethylene glycol))-NHS (N-hydroxysuccinimide) conjugates. Tumor in mice was induced through the use of KB cell culture. Prepared dendritic conjugates were evaluated for the anticancer drug delivery potential using 5-FU (5-fluorouracil) in tumor-bearing mice. Approximately 31% of 5-FU was loaded in folate-PEG-dendritic conjugates. Results indicated that folate-PEG-dendrimer conjugate was significantly safe and effective in tumor targeting compared to a non-PEGylated formulation. Tailoring of dendrimers via PEG-folic acid reduced hemolytic toxicity, which led to a sustained drug release pattern as well as highest accumulation in the tumor area.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Class of Polymers: Starburst-Dendritic Macromolecules
Tomalia, D. A., Baker, H., Dewald, J., Hall, M., Kallos, G., Martin, S., Roeck, J., Ryder, J., & Smith, P. (1985) · Polymer Journal · doi:10.1295/polymj.17.117 · Cited by 3,904
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.014 · Cited by 2,334
Malik, N., Wiwattanapatapee, R., Klopsch, R., Lorenz, K., Frey, H., Weener, J. W., Meijer, E. W., Paulus, W., & Duncan, R. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00246-1 · Cited by 1,227
Encapsulation of Guest Molecules into a Dendritic Box
Jansen, J. F. G. A., de Brabander-van den Berg, E. M. M., & Meijer, E. W. (1994) · Science · doi:10.1126/science.266.5188.1226 · Cited by 1,167
Kukowska-Latallo, J. F., Bielinska, A. U., Johnson, J., Spindler, R., Tomalia, D. A., & Baker, J. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4897 · Cited by 1,006
Folate-mediated delivery of macromolecular anticancer therapeutic agents
Lu, Y., & Low, P. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00042-x · Cited by 941
In Vitro Gene Delivery by Degraded Polyamidoamine Dendrimers
Tang, M. X., Redemann, C. T., & Szoka, F. C. (1996) · Bioconjugate Chemistry · doi:10.1021/bc9600630 · Cited by 808
Dendrimer‐based metal chelates: A new class of magnetic resonance imaging contrast agents
Wiener, E., Brechbiel, M. W., Brothers, H., Magin, R. L., Gansow, O. A., Tomalia, D. A., & Lauterbur, P. C. (1994) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910310102 · Cited by 718
Polymeric micelles as new drug carriers
Kwon, G. S., & Okano, T. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00401-2 · Cited by 710
Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis.
Lee, R. J., & Low, P. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41848-5 · Cited by 692
Kojima, C., Kono, K., Maruyama, K., & Takagishi, T. (2000) · Bioconjugate Chemistry · doi:10.1021/bc0000583 · Cited by 663
Quintana, A., Raczka, E., Piehler, L., Lee, I., Myc, A., Majoros, I., Patri, A. K., Thomas, T., Mulé, J., & Baker, J. R. (2002) · Pharmaceutical Research · doi:10.1023/a:1020398624602 · Cited by 663
Preliminary biological evaluation of polyamidoamine (PAMAM) StarburstTM dendrimers
Roberts, J. C., Bhalgat, M. K., & Zera, R. T. (1996) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(199601)30:1<53::aid-jbm8>3.0.co;2-q · Cited by 589
A PEGylated dendritic nanoparticulate carrier of fluorouracil
Bhadra, D., Bhadra, S., Jain, S., & Jain, N. K. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00132-7 · Cited by 544
Self-citationBielinska, A. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.11.2176 · Cited by 451
Yoo, H. S., & Park, T. G. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.08.017 · Cited by 444
Vandamme, T. F., & Brobeck, L. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.015 · Cited by 401
Newkome, G. R., Moorefield, C. N., Baker, G. R., Saunders, M. J., & Grossman, S. H. (1991) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199111781 · Cited by 386
Dendrimers: Novel Polymeric Nanoarchitectures for Solubility Enhancement
Gupta, U., Agashe, H. B., Asthana, A., & Jain, N. K. (2006) · Biomacromolecules · doi:10.1021/bm050802s · Cited by 375
Self-citationDendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin
Chauhan, A. S., Sridevi, S., Chalasani, K. B., Jain, A. K., Jain, S. K., Jain, N. K., & Diwan, P. V. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00200-1 · Cited by 344
Self-citationGarin‐Chesa, P., Campbell, I., Saigo, P. E., Lewis, J. L., Old, L. J., & Rettig, W. J. (1993) · PubMed Central · Cited by 299
Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting
Bhadra, D., Yadav, A. K., Bhadra, S., & Jain, N. K. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.01.026 · Cited by 280
Self-citationChoi, Y., Thomas, T., Kotlyar, A., Islam, M. T., & Baker, J. R. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.10.016 · Cited by 245
Agrawal, P., Gupta, U., & Jain, N. K. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.04.004 · Cited by 241
Self-citationDesign of Dendritic Macromolecules Containing Folate or Methotrexate Residues
Kono, K., Liu, M., & Fréchet, J. M. J. (1999) · Bioconjugate Chemistry · doi:10.1021/bc990082k · Cited by 207
Duncan, R. (1999) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(99)00211-4 · Cited by 192
de Wolf, F. A., & Brett, G. M. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01447-9 · Cited by 186
Activity of Dendrimer−Methotrexate Conjugates on Methotrexate-Sensitive and -Resistant Cell Lines
Gurdag, S., Khandare, J., Stapels, S., Matherly, L. H., & Kannan, R. M. (2006) · Bioconjugate Chemistry · doi:10.1021/bc0501855 · Cited by 165
Kihara, F., Arima, H., Tsutsumi, T., Hirayama, F., & Uekama, K. (2003) · Bioconjugate Chemistry · doi:10.1021/bc025613a · Cited by 161
Zhao, X. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.005 · Cited by 153
Preferential liver gene expression with polypropylenimine dendrimers
Schätzlein, A. G., Zinselmeyer, B. H., Elouzi, A., Dufès, C., Chim, Y. T. A., Roberts, C. J., Davies, M. C., Munro, A., Gray, A. I., & Uchegbu, I. F. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.08.024 · Cited by 132
Lim, Y., Kim, T. I., Lee, J. W., Kim, S.-M., Kim, H.-J., Kim, K., & Park, J. S. (2002) · Bioconjugate Chemistry · doi:10.1021/bc025581r · Cited by 127
Pharmaceutical and Biomedical Potential of PEGylated Dendrimers
Gajbhiye, V., Kumar, P. V., Tekade, R. K., & Jain, S. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780162999 · Cited by 124
Preparation and characterization of folate-targeted pEG-coated pDMAEMA-based polyplexes
van Steenis, J. H., van Maarseveen, E. M., Verbaan, F. J., Verrijk, R., Crommelin, D. J. A., Storm, G., & Hennink, W. E. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00361-9 · Cited by 118
Ligand based dendritic systems for tumor targeting
Agarwal, A., Saraf, S., Asthana, A., Gupta, U. D., Gajbhiye, V., & Jain, N. K. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.09.024 · Cited by 112
Self-citationKannan, S., Kolhe, P., Raykova, V., Glibatec, M., Kannan, R. M., Lieh-Lai, M. W., & Bassett, D. J. P. (2004) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856204322977201 · Cited by 107
PEGylated Peptide Dendrimeric Carriers for the Delivery of Antimalarial Drug Chloroquine Phosphate
Bhadra, D., Bhadra, S., & Jain, N. K. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-9396-9 · Cited by 102
Self-citationThe future of open- and closed-loop insulin delivery systems
Farmer, T. G., Edgar, T. F., & Peppas, N. A. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.1.0001 · Cited by 86
Delivery systems for intraocular routes
Peyman, G. A., & Ganiban, G. J. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00018-3 · Cited by 85
Pharmaceutical and Biomedical Potential of Surface Engineered Dendrimers
Satija, J., Gupta, U. D., & Jain, N. K. (2007) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v24.i3.20 · Cited by 75
Self-citationTrasler, J. M. (2003) · Carcinogenesis · doi:10.1093/carcin/24.1.39 · Cited by 68
Cited by
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Nanoparticles as drug delivery systems
Wilczewska, A. Z., Niemirowicz, K., Markiewicz, K. H., & Car, H. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70901-5 · Cited by 1,445
Imaging and drug delivery using theranostic nanoparticles
Janib, S. M., Moses, A. S., & MacKay, J. A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.08.004 · Cited by 1,248
Dendrimer toxicity: Let's meet the challenge
Jain, K., Kesharwani, P., Gupta, U., & Jain, N. K. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.027 · Cited by 710
Self-citationEmerging concepts in dendrimer‐based nanomedicine: from design principles to clinical applications
Kannan, R. M., Nance, E., Kannan, S., & Tomalia, D. A. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12280 · Cited by 542
Metadata
- Authors
- Singh, P., Gupta, U., Asthana, A., & Jain, N. K.
- Venue
- Bioconjugate Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2008-10-25
- Volume
- 19
- Issue
- 11
- Pages
- 2239-2252
- ISSN
- 1043-1802 (ISSN-L)
- 1520-4812
- OpenAlex
- W1981116681
- Cited by
- 329
- References
- 42
- FWCI
- 15.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.